Aisling Capital Iii Lp

Affiliations

  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LOXO $31.00 160,000 $4,960,000.00 4,188,920 2017-01-10 Filing
SYRS $12.50 400,000 $5,000,000.00 908,565 2016-07-06 Filing
LOXO $21.50 232,558 $4,999,997.00 4,028,920 2016-05-17 Filing
LOXO $27.50 200 $5,500.00 3,796,362 2015-12-11 Filing
TTOO $9.75 307,692 $2,999,997.00 2,830,992 2015-12-09 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LOXO $179.43 1,400,000 $251,202,000.00 2,038,920 2018-07-10 Filing
LOXO $80.50 250,000 $20,125,000.00 3,438,920 2017-12-19 Filing
LOXO $75.00 500,000 $37,500,000.00 3,688,920 2017-11-22 Filing
DRTX $15.57 2,649 $41,255.00 3,030,175 2014-03-21 Filing
DRTX $15.74 98,000 $1,542,588.60 3,032,824 2014-03-20 Filing